Sex differences in subclinical coronary atherosclerotic plaque among individuals with HIV on antiretroviral therapy
Journal of Acquired Immune Deficiency Syndromes Jul 11, 2018
Foldyna B, et al. - Given that women compared to men display a higher HIV-attributable risk of myocardial infarction (MI) in high-resource settings, researchers investigated the extent to which unique mechanisms contribute to MI risk among women vs men with HIV. They performed a comparison of subclinical coronary atherosclerotic plaque characteristics—including high-risk morphology plaque features—among 48 HIV-infected women [48 (41, 54) years] and 97 HIV-infected men [48 (42, 52) years] on stable antiretroviral therapy (ART) without known cardiovascular disease. Findings revealed a lower prevalence and burden of subclinical coronary plaque and high-risk morphology plaque among ART-treated HIV-infected women (vs HIV-infected men). Thereby suggesting unique sex-specific mechanisms beyond subclinical plaque to drive the higher HIV-attributable risk of MI among women vs men.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries